Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Zhang, Y [1 ]
Zhang, L [1 ]
Li, N [1 ]
Xu, F [1 ]
Pan, ZK [1 ]
Guang, ZZ [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：702S / 702S
页数：1
相关论文
共 50 条
  • [1] The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non-small cell lung cancer
    Koemuercueoglu, B.
    Aydogan, H.
    Tekguel, S.
    Cecen, E.
    Yalniz, E.
    Oezden, E. Pala
    [J]. LUNG CANCER, 2006, 52 : S36 - S36
  • [2] Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer
    Barón, F
    Cueva, J
    Graña, B
    Curiel, T
    León, L
    Vázquez, F
    Candamio, S
    López, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) : 1381 - 1384
  • [3] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [4] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [5] Gemcitabine (GEM) plus vinorelbine (NVB) in non-small cell lung cancer (NSCLC)
    Michetti, G
    Beretta, GD
    Belometti, MO
    Gritti, G
    Marini, B
    Agazzi, A
    Labianca, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 91 - 92
  • [6] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [7] A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaive patients with stage III and IV non-small cell lung cancer (NSCLC)
    Teodorescu, G
    Ciuleanu, T
    Grigorescu, A
    Firoiu, E
    Muresan, DR
    [J]. LUNG CANCER, 2005, 49 : S271 - S272
  • [8] A cost analysis of treatment with bevacizumab plus cisplatin and gemcitabine (BCG) versus cetuximab plus vinorelbine and cisplatin (CVC) in patients with advanced or recurrent non-small cell lung cancer (NSCLC) in Germany
    Heigener, D. F.
    Wiesner, C.
    Aultman, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [10] Phase mi study of Gemcitabine plus vinorelbine in non-small cell lung cancer (NSCLC)
    Puertas, J
    Esteban, E
    Fra, J
    Liano, JLG
    Vieitez, JM
    Estrada, E
    Palacio, I
    Muniz, I
    Buesa, JM
    Lacave, AJ
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
12345